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stem cells (iPSCs) and differentiating them into functional human
cells. FCDI aims to establish a bank of HLA-matched iPSCs
spanning >95% of the US population and, by extension, establish
banks that match against global populations. Historical work with
cord blood and solid organ transplantation indicate that a hemizy-
gous recipient match at specific HLA loci reduces incidence of
allograft rejection. Therefore, blood from individuals possessing
these desirable HLA types along with additional criteria to mini-
mize risk of rejectionwill be used in themanufacture of banks using
FCDI’s proprietary, plasmid-based reprogramming technology.
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New regenerative medicine approaches to treat haemophilia A
require insights into cell compartments capable of producing factor
VIII (FVIII). Haemaphilia A (HA) is an X-linked bleeding disease
due to FVIII deficiency. We and others previously demonstrated
that FVIII is produced specifically in endothelial cells. The main
objective of our work is to develop the tools and technologies for a
novel ex vivo cell-based therapy to treat HA that should ultimately
lead to improved patient quality of life. We isolated blood out-
growth endothelial cells (BOECs) from healthy and patients’ blood.
BOECs were efficiently transduced by lentiviral vectors (LVs)
containing the B domain deleted form of human FVIII under the
Vascular Endothelial Cadherin promoter (VEC). BOECs were
characterized by FACS analysis for endothelial phenotype and
FVIII evaluated by APTT and ELISA. The number of integrated
LV copies/cell was *3 for LV-VEC.hFVIII transduced cells.
We demonstrated by FACS that FVIII was expressed by 70%
of transduced cells. Ten million LV-VEC.hFVIII-BOECs were
transplanted intraperitoneally in association with cytodex 3
microcarrier beads in NOD/SCID c-null HA (NSG-HA) mice
(n = 3). BOECs survived and secreted FVIII at therapeutic
levels (with a peak of 15% FVIII activity) for up to 12 weeks.
As next steps, LV-transduced haemophilia patient BOECs will
be transplanted into an implanted prevascularized, scalable
medical device (Cell Pouch, Sernova Corp.) and optimized
for sustained secretion of FVIII in the NSG-HA mice. This is in
preparation for future human clinical testing within the device
in haemophilic patients by transplantation of GMP produced
autologous gene corrected BOECs.
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Tissue regeneration at the site of non-healing oroantral fistula
with simultaneous plastic surgery reconstruction of soft tissues
was carried out. Adipose tissue derived stromal vascular fraction
(SVF) in combination with nickel-titanium granules (nitigran)
was used as an osteoinductive material. We performed excision
of the altered mucosa in the fistula. The granulations from the
sinus cavity were taken out. The sinus cavity was repeatedly
washed with antiseptic solutions. The bone surface was treated
with milling cuts along the entire length of the fistulous course.
The bottom of the defect was covered with a membrane, and the
defect was filled with nickel-titanium granules saturated with
SVF. The top was covered with a collagen membrane. Then the
plastic surgery of the fistula with soft tissues was performed. The
edges of the wound were stitched with Vicryl and additionally
covered with Tissucol fibrin glue mixed with SVF. In the course
of the wound healing, fibrin glue dissolved completely, releasing
the cells enclosed in it, which stimulated regeneration processes.
The dog was prescribed to undergo the antibiotic therapy with
Maxipime at a dose of 250mg given intramuscularly once a day
for 5 days. Subsequently, dynamic X-ray examination of the
animal and external examinations were carried out. As a result of
the operation, the full closure of the oroantral fistula in the dog’s
jaw was achieved, which demonstrates the effectiveness of ni-
tigran granules in comvination with adipose derived SVF in
complex non-healing wounds of soft tissues in maxillofacial
surgery.
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Human induced pluripotent stem cells (hiPSCs) hold great
promise for regenerative medicine, particularly for develop-
ment of personalized therapies for human patients. One of the
most common life-threatening diseases in developed coun-
tries nowadays are related to the cardiovascular system, de-
spite available modalities. Thus, it is of immense importance
to develop new treatment options for affected patients, in-
cluding standardized and robust protocols for cardiomyocytes
generation from patients’ own samples, with or without the
iPSC-stage. Knowing that reduced oxygen level (hypoxia)
plays an important role in normal cardiomyogenesis in vivo,
we hypothesized, that low oxygen condition may also influ-
ence cardiomyocytes generation from hiPSCs in vitro. In this
study we performed cardiomyogenic differentiation from
isogenic hiPS cell lines cultured continuously in hypoxia and
normoxia. We found that hiPSCs cultured in hypoxia differ-
entiated faster into mature cardiomyocytes, in comparison to
their counterparts derived from normoxic cultures. The dif-
ferentiation was indicated by increased levels of expression of
pro-cardiomyogenic genes, including GATA4, NKX2.5 and
TNNT2 and also higher mRNA levels for calcium, potassium
and sodium ion channels, an indicator of mature cardiomyo-
cytes. We conclude, that hypoxia preconditioning increases
the ability of hiPSCs to differentiate into mature cardio-
myocytes. Our findings might be implemented into protocols
for cardiac myocytes generation in a more robust and physi-
ological way. These data can further be exploited for prepa-
ration of drugs screening platforms and ultimately, for
development of novel therapies for human patients based on
iPS-derived allogeneic cardiac cells.
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